Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for SCLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 101.51M
March 31, 2026 101.87M
December 31, 2025 127.29M
September 30, 2025 62.39M
June 30, 2025 48.60M
March 31, 2025 48.07M
December 31, 2024 44.04M
September 30, 2024 100.68M
June 30, 2024 106.30M
March 31, 2024 111.31M
December 31, 2023 127.70M
September 30, 2023 9.334M
Date Value
June 30, 2023 18.51M
March 31, 2023 0.461M
December 31, 2022 0.665M
September 30, 2022 5.007M
June 30, 2022 4.034M
March 31, 2022 2.026M
December 31, 2021 134.64M
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. 0.484M
Semnur Pharmaceuticals, Inc. 20.94M
ANI Pharmaceuticals, Inc. 610.49M
Corcept Therapeutics, Inc. 7.504M
Veru, Inc. 1.908M